According to the latest market research study by Technavio, the global stem cell therapy market is expected to grow at a CAGR of close to 37% during the forecast period 2017 to 2021.
This report by Technavio provides an in-depth analysis of the global stem cell therapy market in terms of revenue and emerging market trends. The report also includes a competitive vendor analysis and forecasts for various market segments and all geographical segmentations.
Technavio research analysts categorize the market based on the applications
Click here to request a free sample of this report
The top three revenue contributing applications are discussed below
Dermatology: Stem treatment for dermatology is used to rejuvenate aging and damaged skin due to burns and chronic wounds. With the society being fascinated by appearance and people growing more concern about their aesthetic look, the demand for stem cell therapy products in dermatology is projected to rise, thereby permitting vendors to seize the market opportunity.
“Vendors such as Anterogen, RHEACELL, Kangstem Biotech, and Beike Biotechnology are extensively developing stem cell therapy products in dermatology segment. Most of the products that are under clinical trial are developed through gene therapy. There are around ten products in the pipeline including eight in Phase II development stage,” says Sapna Jha, a lead analyst at Technavio for research on medical imaging.
Musculoskeletal: Musculoskeletal disorders happen when there are injuries to the joints and the soft tissue. Several vendors in the market are focusing on developing stem therapy products for musculoskeletal disorders. For instance, Mesoblast’s MPC injections help replace lost cartilage and proteoglycan in degenerated intervertebral discs, which helps the disc regain its functional properties. Such initiatives taken by the vendors will fuel the market growth.
Cardiovascular: The treatment of cardiovascular diseases does not provide curative or reparative development. Several companies are conducting clinical trials to develop cardiomyocytes derived from human pluripotent stem cells (hPSCs), which are expected to improve the functioning of the heart. Vendors are increasingly developing stem cells based on the use of allogeneic mesenchymal precursor cells. Autologous stem cell treatment is also gaining traction in the market, owing to its increased advantages for treating cardiovascular disorders.
Ask an analyst to know more about this report
The top vendors operating in the global stem cell therapy market are:
- Holostem Advanced Therapies
- JCR Pharmaceuticals
- Organogenesis
- Osiris Therapeutics
- Vericel
The other prominent vendors in the market include AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, BrainStorm Cell Therapeutics, Brainxell, Caladrius Biosciences, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells Group, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Osiris Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec Corporation, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.
A more detailed analysis is available in the Technavio market research report titled, ‘Global Stem Cell Therapy Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports
- Global Spine Biologics Market 2016-2020
- Global Transplant Diagnostics Market 2016-2020
- Global Orthobiologics Market 2016-2020
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
